text
"['\n7. 증권의 발행을 통한 자금조달에 관한 사항\n7-1. 증권의 발행을 통한 자금조달 실적\n[지분증권의 발행 등과 관련된 사항]\n가. 증자(감자)현황\n(기준일 :\xa0\n2021년 09월 30일\n)\n(단위 : 원, 주)\n주식발행(감소)일자\n발행(감소)형태\n발행(감소)한 주식의 내용\n종류\n수량\n주당액면가액\n주당발행(감소)가액\n비고\n-\n-\n-\n-\n-\n-\n-\n- 해당사항 없음.\n[채무증권의 발행 등과 관련된 사항]\n채무증권 발행실적\n(기준일 :\xa0\n2021년 09월 30일\n)\n(단위 : 백만원, %)\n발행회사\n증권종류\n발행방법\n발행일자\n권면(전자등록)총액\n이자율\n평가등급(평가기관)\n만기일\n상환여부\n주관회사\n유진투자증권\n기업어음증권\n사모\n2021.01.07\n5,000\n1.31\nA2+(NICE신용평가), A2+(한신평)\n2021.07.08\n상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.01.07\n5,000\n1.31\nA2+(NICE신용평가), A2+(한신평)\n2021.07.08\n상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.01.07\n5,000\n1.31\nA2+(NICE신용평가), A2+(한신평)\n2021.07.08\n상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.01.07\n5,000\n1.31\nA2+(NICE신용평가), A2+(한신평)\n2021.07.08\n상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.01.07\n5,000\n1.31\nA2+(NICE신용평가), A2+(한신평)\n2021.07.07\n상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.01.07\n5,000\n1.31\nA2+(NICE신용평가), A2+(한신평)\n2021.07.07\n상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.01.07\n5,000\n1.31\nA2+(NICE신용평가), A2+(한신평)\n2021.07.07\n상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.01.07\n5,000\n1.31\nA2+(NICE신용평가), A2+(한신평)\n2021.07.07\n상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.01.07\n5,000\n1.31\nA2+(NICE신용평가), A2+(한신평)\n2021.07.07\n상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.01.07\n5,000\n1.31\nA2+(NICE신용평가), A2+(한신평)\n2021.07.07\n상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.01.12\n5,000\n1.19\nA2+(NICE신용평가), A2+(한신평)\n2021.10.12\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.01.12\n5,000\n1.19\nA2+(NICE신용평가), A2+(한신평)\n2021.10.12\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.01.12\n5,000\n1.19\nA2+(NICE신용평가), A2+(한신평)\n2021.10.12\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.01.12\n5,000\n1.19\nA2+(NICE신용평가), A2+(한신평)\n2021.10.12\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.01.12\n5,000\n1.19\nA2+(NICE신용평가), A2+(한신평)\n2021.10.12\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.01.12\n5,000\n1.19\nA2+(NICE신용평가), A2+(한신평)\n2021.10.12\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.01.12\n5,000\n1.19\nA2+(NICE신용평가), A2+(한신평)\n2021.10.12\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.01.12\n5,000\n1.19\nA2+(NICE신용평가), A2+(한신평)\n2021.10.12\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.01.12\n5,000\n1.19\nA2+(NICE신용평가), A2+(한신평)\n2021.10.12\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.01.12\n5,000\n1.19\nA2+(NICE신용평가), A2+(한신평)\n2021.10.12\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.01.22\n5,000\n1.11\nA2+(NICE신용평가), A2+(한신평)\n2021.10.22\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.01.22\n5,000\n1.11\nA2+(NICE신용평가), A2+(한신평)\n2021.10.22\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.01.22\n5,000\n1.11\nA2+(NICE신용평가), A2+(한신평)\n2021.10.22\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.01.22\n5,000\n1.11\nA2+(NICE신용평가), A2+(한신평)\n2021.10.22\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.01.22\n5,000\n1.11\nA2+(NICE신용평가), A2+(한신평)\n2021.10.22\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.01.22\n5,000\n1.11\nA2+(NICE신용평가), A2+(한신평)\n2021.10.22\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.01.22\n10,000\n1.11\nA2+(NICE신용평가), A2+(한신평)\n2021.10.22\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.01.22\n10,000\n1.11\nA2+(NICE신용평가), A2+(한신평)\n2021.10.22\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.02.15\n5,000\n1.11\nA2+(NICE신용평가), A2+(한신평)\n2022.02.14\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.02.15\n5,000\n1.11\nA2+(NICE신용평가), A2+(한신평)\n2022.02.14\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.02.15\n5,000\n1.11\nA2+(NICE신용평가), A2+(한신평)\n2022.02.14\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.02.15\n5,000\n1.11\nA2+(NICE신용평가), A2+(한신평)\n2022.02.14\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.02.15\n5,000\n1.11\nA2+(NICE신용평가), A2+(한신평)\n2022.02.14\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.02.15\n5,000\n1.11\nA2+(NICE신용평가), A2+(한신평)\n2022.02.14\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.03.04\n5,000\n1.00\nA2+(NICE신용평가), A2+(한신평)\n2021.09.06\n상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.03.04\n5,000\n1.00\nA2+(NICE신용평가), A2+(한신평)\n2021.09.06\n상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.03.04\n10,000\n1.00\nA2+(NICE신용평가), A2+(한신평)\n2021.06.04\n상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.03.04\n10,000\n1.00\nA2+(NICE신용평가), A2+(한신평)\n2021.06.04\n상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.03.08\n5,000\n1.21\nA2+(NICE신용평가), A2+(한신평)\n2022.03.07\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.03.08\n5,000\n1.21\nA2+(NICE신용평가), A2+(한신평)\n2022.03.07\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.03.08\n5,000\n1.21\nA2+(NICE신용평가), A2+(한신평)\n2022.03.07\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.03.08\n5,000\n1.21\nA2+(NICE신용평가), A2+(한신평)\n2022.03.07\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.03.08\n5,000\n1.21\nA2+(NICE신용평가), A2+(한신평)\n2022.03.07\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.03.08\n5,000\n1.21\nA2+(NICE신용평가), A2+(한신평)\n2022.03.07\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.03.16\n30,000\n1.25\nA2+(NICE신용평가), A2+(한신평)\n2022.03.15\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.04.01\n20,000\n1.05\nA2+(NICE신용평가), A2+(한신평)\n2021.11.01\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.04.02\n5,000\n1.01\nA2+(NICE신용평가), A2+(한신평)\n2021.08.02\n상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.04.02\n5,000\n1.01\nA2+(NICE신용평가), A2+(한신평)\n2021.08.02\n상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.04.02\n5,000\n1.01\nA2+(NICE신용평가), A2+(한신평)\n2021.08.02\n상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.04.02\n5,000\n1.01\nA2+(NICE신용평가), A2+(한신평)\n2021.08.02\n상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.04.05\n5,000\n1.16\nA2+(NICE신용평가), A2+(한신평)\n2022.04.04\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.04.05\n5,000\n1.16\nA2+(NICE신용평가), A2+(한신평)\n2022.04.04\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.04.05\n5,000\n1.16\nA2+(NICE신용평가), A2+(한신평)\n2022.04.04\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.04.05\n5,000\n1.16\nA2+(NICE신용평가), A2+(한신평)\n2022.04.04\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.04.06\n5,000\n1.05\nA2+(NICE신용평가), A2+(한신평)\n2021.11.01\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.04.06\n5,000\n1.05\nA2+(NICE신용평가), A2+(한신평)\n2021.11.01\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.04.06\n5,000\n1.05\nA2+(NICE신용평가), A2+(한신평)\n2021.11.01\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.04.06\n5,000\n1.05\nA2+(NICE신용평가), A2+(한신평)\n2021.11.01\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.04.21\n5,000\n1.09\nA2+(NICE신용평가), A2+(한신평)\n2022.04.20\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.04.21\n5,000\n1.09\nA2+(NICE신용평가), A2+(한신평)\n2022.04.20\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.04.21\n5,000\n1.09\nA2+(NICE신용평가), A2+(한신평)\n2022.04.20\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.04.21\n5,000\n1.09\nA2+(NICE신용평가), A2+(한신평)\n2022.04.20\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.05.14\n5,000\n0.95\nA2+(NICE신용평가), A2+(한신평)\n2021.11.15\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.05.14\n5,000\n0.95\nA2+(NICE신용평가), A2+(한신평)\n2021.11.15\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.05.14\n5,000\n0.95\nA2+(NICE신용평가), A2+(한신평)\n2021.11.15\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.05.14\n5,000\n0.95\nA2+(NICE신용평가), A2+(한신평)\n2021.11.15\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.05.14\n5,000\n0.95\nA2+(NICE신용평가), A2+(한신평)\n2021.11.15\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.05.14\n5,000\n0.95\nA2+(NICE신용평가), A2+(한신평)\n2021.11.15\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.06.04\n20,000\n1.00\nA2+(NICE신용평가), A2+(한신평)\n2021.09.03\n상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.07.08\n5,000\n1.31\nA2+(NICE신용평가), A2+(한신평)\n2022.01.07\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.07.08\n5,000\n1.31\nA2+(NICE신용평가), A2+(한신평)\n2022.01.07\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.07.08\n5,000\n1.31\nA2+(NICE신용평가), A2+(한신평)\n2022.01.07\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.07.08\n5,000\n1.31\nA2+(NICE신용평가), A2+(한신평)\n2022.01.07\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.07.08\n5,000\n1.31\nA2+(NICE신용평가), A2+(한신평)\n2022.01.07\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.07.08\n5,000\n1.31\nA2+(NICE신용평가), A2+(한신평)\n2022.01.07\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.07.15\n5,000\n1.31\nA2+(NICE신용평가), A2+(한신평)\n2022.01.14\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.07.15\n5,000\n1.31\nA2+(NICE신용평가), A2+(한신평)\n2022.01.14\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.07.20\n5,000\n1.31\nA2+(NICE신용평가), A2+(한신평)\n2022.01.21\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.07.20\n5,000\n1.31\nA2+(NICE신용평가), A2+(한신평)\n2022.01.21\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.07.20\n5,000\n1.31\nA2+(NICE신용평가), A2+(한신평)\n2022.01.21\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.07.20\n5,000\n1.31\nA2+(NICE신용평가), A2+(한신평)\n2022.01.21\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.07.20\n5,000\n1.45\nA2+(NICE신용평가), A2+(한신평)\n2022.07.19\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.07.20\n5,000\n1.45\nA2+(NICE신용평가), A2+(한신평)\n2022.07.19\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.07.20\n5,000\n1.31\nA2+(NICE신용평가), A2+(한신평)\n2022.01.14\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.08.02\n5,000\n1.31\nA2+(NICE신용평가), A2+(한신평)\n2022.01.24\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.08.02\n5,000\n1.31\nA2+(NICE신용평가), A2+(한신평)\n2022.01.24\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.09.02\n5,000\n1.72\nA2+(NICE신용평가), A2+(한신평)\n2022.03.02\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.09.02\n5,000\n1.72\nA2+(NICE신용평가), A2+(한신평)\n2022.03.02\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.09.02\n5,000\n1.88\nA2+(NICE신용평가), A2+(한신평)\n2022.08.31\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.09.02\n5,000\n1.88\nA2+(NICE신용평가), A2+(한신평)\n2022.08.31\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.09.02\n5,000\n1.88\nA2+(NICE신용평가), A2+(한신평)\n2022.08.31\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.09.02\n5,000\n1.88\nA2+(NICE신용평가), A2+(한신평)\n2022.08.31\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.09.03\n10,000\n1.40\nA2+(NICE신용평가), A2+(한신평)\n2021.12.03\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.09.03\n10,000\n1.40\nA2+(NICE신용평가), A2+(한신평)\n2021.12.03\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.09.03\n5,000\n1.88\nA2+(NICE신용평가), A2+(한신평)\n2022.09.02\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.09.03\n5,000\n1.88\nA2+(NICE신용평가), A2+(한신평)\n2022.09.02\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.09.06\n10,000\n1.88\nA2+(NICE신용평가), A2+(한신평)\n2022.09.05\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.09.06\n10,000\n1.88\nA2+(NICE신용평가), A2+(한신평)\n2022.09.05\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.09.07\n5,000\n1.89\nA2+(NICE신용평가), A2+(한신평)\n2022.09.06\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.09.07\n5,000\n1.89\nA2+(NICE신용평가), A2+(한신평)\n2022.09.06\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.09.07\n5,000\n1.89\nA2+(NICE신용평가), A2+(한신평)\n2022.09.06\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.09.07\n5,000\n1.89\nA2+(NICE신용평가), A2+(한신평)\n2022.09.06\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.09.10\n5,000\n1.81\nA2+(NICE신용평가), A2+(한신평)\n2022.03.10\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.09.10\n5,000\n1.81\nA2+(NICE신용평가), A2+(한신평)\n2022.03.10\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.09.17\n5,000\n2.01\nA2+(NICE신용평가), A2+(한신평)\n2022.01.17\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.09.17\n5,000\n2.01\nA2+(NICE신용평가), A2+(한신평)\n2022.01.17\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.09.17\n5,000\n2.01\nA2+(NICE신용평가), A2+(한신평)\n2022.01.17\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.09.17\n5,000\n2.01\nA2+(NICE신용평가), A2+(한신평)\n2022.01.17\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.09.17\n5,000\n2.01\nA2+(NICE신용평가), A2+(한신평)\n2022.01.17\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.09.17\n5,000\n2.01\nA2+(NICE신용평가), A2+(한신평)\n2022.01.17\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.09.17\n5,000\n2.01\nA2+(NICE신용평가), A2+(한신평)\n2022.01.17\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.09.17\n5,000\n2.01\nA2+(NICE신용평가), A2+(한신평)\n2022.01.17\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.09.17\n5,000\n2.01\nA2+(NICE신용평가), A2+(한신평)\n2022.01.17\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.09.17\n5,000\n2.01\nA2+(NICE신용평가), A2+(한신평)\n2022.01.26\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.09.17\n5,000\n2.01\nA2+(NICE신용평가), A2+(한신평)\n2022.01.26\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.09.29\n5,000\n2.02\nA2+(NICE신용평가), A2+(한신평)\n2022.03.28\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.09.29\n5,000\n2.02\nA2+(NICE신용평가), A2+(한신평)\n2022.03.28\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.09.29\n5,000\n2.02\nA2+(NICE신용평가), A2+(한신평)\n2022.03.28\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.09.29\n5,000\n2.02\nA2+(NICE신용평가), A2+(한신평)\n2022.03.28\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.09.29\n5,000\n2.02\nA2+(NICE신용평가), A2+(한신평)\n2022.03.28\n미상환\n-\n유진투자증권\n기업어음증권\n사모\n2021.09.29\n5,000\n2.02\nA2+(NICE신용평가), A2+(한신평)\n2022.03.28\n미상환\n-\n유진투자증권\n전자단기사채\n사모\n2021.01.05\n20,000\n1.21\nA2+(NICE신용평가), A2+(한신평)\n2021.04.05\n상환\n-\n유진투자증권\n전자단기사채\n사모\n2021.02.03\n20,000\n0.99\nA2+(NICE신용평가), A2+(한신평)\n2021.05.03\n상환\n-\n유진투자증권\n전자단기사채\n사모\n2021.02.03\n10,000\n0.99\nA2+(NICE신용평가), A2+(한신평)\n2021.05.03\n상환\n-\n유진투자증권\n전자단기사채\n사모\n2021.02.22\n20,000\n0.95\nA2+(NICE신용평가), A2+(한신평)\n2021.05.21\n상환\n-\n유진투자증권\n전자단기사채\n사모\n2021.03.03\n10,000\n0.95\nA2+(NICE신용평가), A2+(한신평)\n2021.06.03\n상환\n-\n유진투자증권\n전자단기사채\n사모\n2021.03.16\n20,000\n1.06\nA2+(NICE신용평가), A2+(한신평)\n2021.06.16\n상환\n-\n유진투자증권\n전자단기사채\n사모\n2021.05.06\n20,000\n0.91\nA2+(NICE신용평가), A2+(한신평)\n2021.08.06\n상환\n-\n유진투자증권\n전자단기사채\n사모\n2021.07.21\n20,000\n1.14\nA2+(NICE신용평가), A2+(한신평)\n2021.10.21\n미상환\n-\n유진투자증권\n전자단기사채\n사모\n2021.08.04\n10,000\n1.21\nA2+(NICE신용평가), A2+(한신평)\n2021.10.28\n미상환\n-\n유진투자증권\n전자단기사채\n사모\n2021.08.05\n20,000\n1.21\nA2+(NICE신용평가), A2+(한신평)\n2021.11.05\n미상환\n-\n유진투자증권\n전자단기사채\n사모\n2021.08.12\n10,000\n1.23\nA2+(NICE신용평가), A2+(한신평)\n2021.11.12\n미상환\n-\n유진투자증권\n전자단기사채\n사모\n2021.08.13\n10,000\n1.23\nA2+(NICE신용평가), A2+(한신평)\n2021.11.12\n미상환\n-\n유진투자증권\n전자단기사채\n사모\n2021.09.02\n30,000\n1.52\nA2+(NICE신용평가), A2+(한신평)\n2021.12.02\n미상환\n-\n유진에이티제일차(주)\n전자단기사채\n사모\n2021.05.11\n20,000\n1.20\nA2+(한신평), A2+(한기평)\n2021.08.11\n상환\n유진투자증권\n유진에이티제일차(주)\n전자단기사채\n사모\n2021.08.11\n20,000\n1.35\nA2+(한신평), A2+(한기평)\n2021.11.11\n미상환\n유진투자증권\n엔에이디제일차㈜\n전자단기사채\n사모\n2021.04.30\n27,000\n1.25\nA2+(한신평), A2+(한기평)\n2021.05.31\n상환\n유진투자증권\n엔에이디제일차㈜\n전자단기사채\n사모\n2021.05.31\n27,000\n1.20\nA2+(한신평), A2+(한기평)\n2021.06.29\n상환\n유진투자증권\n엔에이디제일차㈜\n전자단기사채\n사모\n2021.06.29\n27,000\n1.25\nA2+(한신평), A2+(한기평)\n2021.07.29\n상환\n유진투자증권\n엔에이디제일차㈜\n전자단기사채\n사모\n2021.07.29\n27,000\n1.30\nA2+(한신평), A2+(한기평)\n2021.08.31\n상환\n유진투자증권\n엔에이디제일차㈜\n전자단기사채\n사모\n2021.08.31\n27,000\n1.40\nA2+(한신평), A2+(한기평)\n2021.09.30\n상환\n유진투자증권\n엔에이디제일차㈜\n전자단기사채\n사모\n2021.09.30\n27,000\n1.95\nA2+(한신평), A2+(한기평)\n2021.10.30\n미상환\n유진투자증권\n챔피언별내제일차\n전자단기사채\n사모\n2021.08.26\n15,000\n1.60\nA2+(한신평), A2+(한기평)\n2021.11.26\n미상환\n유진투자증권\n해피니스레드\n전자단기사채\n사모\n2021.09.24\n10,000\n1.85\nA2+(NICE신용평가), A2+(한신평)\n2021.11.24\n미상환\n유진투자증권\n네버에버제일차\n전자단기사채\n사모\n2021.09.29\n90,000\n1.85\nA2+(NICE신용평가), A2+(한신평)\n2021.10.29\n미상환\n유진투자증권\n합\xa0 계\n-\n-\n-\n1,237,000\n-\n-\n-\n-\n-\n기업어음증권 미상환 잔액 (연결기준)\n(기준일 :\xa0\n2021년 09월 30일\n)\n(단위 : 백만원)\n잔여만기\n10일 이하\n10일초과30일이하\n30일초과90일이하\n90일초과180일이하\n180일초과1년이하\n1년초과2년이하\n2년초과3년이하\n3년 초과\n합 계\n미상환 잔액\n공모\n-\n-\n-\n-\n-\n-\n-\n-\n-\n사모\n-\n100,000\n140,000\n270,000\n120,000\n-\n-\n-\n630,000\n합계\n-\n100,000\n140,000\n270,000\n120,000\n-\n-\n-\n630,000\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0 기업어음증권 미상환 잔액 (별도기준)\n(기준일 :\xa0\n2021년 09월 30일\n)\n(단위 : 백만원)\n잔여만기\n10일 이하\n10일초과30일이하\n30일초과90일이하\n90일초과180일이하\n180일초과1년이하\n1년초과2년이하\n2년초과3년이하\n3년 초과\n합 계\n미상환 잔액\n공모\n-\n-\n-\n-\n-\n-\n-\n-\n-\n사모\n-\n100,000\n140,000\n270,000\n120,000\n-\n-\n-\n630,000\n합계\n-\n100,000\n140,000\n270,000\n120,000\n-\n-\n-\n630,000\n단기사채 미상환 잔액 (연결기준)\n(기준일 :\xa0\n2021년 09월 30일\n)\n(단위 : 백만원)\n잔여만기\n10일 이하\n10일초과30일이하\n30일초과90일이하\n90일초과180일이하\n180일초과1년이하\n합 계\n발행 한도\n잔여 한도\n미상환 잔액\n공모\n-\n-\n-\n-\n-\n-\n-\n-\n사모\n-\n147,000\n115,000\n-\n-\n262,000\n-\n-\n합계\n-\n147,000\n115,000\n-\n-\n262,000\n612,000\n350,000\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0 단기사채 미상환 잔액 (별도기준)\n(기준일 :\xa0\n2021년 09월 30일\n)\n(단위 : 백만원)\n잔여만기\n10일 이하\n10일초과30일이하\n30일초과90일이하\n90일초과180일이하\n180일초과1년이하\n합 계\n발행 한도\n잔여 한도\n미상환 잔액\n공모\n-\n-\n-\n-\n-\n-\n-\n-\n사모\n-\n30,000\n70,000\n-\n-\n100,000\n-\n-\n합계\n-\n30,000\n70,000\n-\n-\n100,000\n450,000\n350,000\n회사채 미상환 잔액 (연결기준)\n(기준일 :\xa0\n2021년 09월 30일\n)\n(단위 : 백만원)\n잔여만기\n1년 이하\n1년초과2년이하\n2년초과3년이하\n3년초과4년이하\n4년초과5년이하\n5년초과10년이하\n10년초과\n합 계\n미상환 잔액\n공모\n-\n-\n-\n-\n-\n-\n-\n-\n사모\n-\n10,000\n-\n-\n-\n40,000\n-\n50,000\n합계\n-\n10,000\n-\n-\n-\n40,000\n-\n50,000\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0 회사채 미상환 잔액 (별도기준)\n(기준일 :\xa0\n2021년 09월 30일\n)\n(단위 : 백만원)\n잔여만기\n1년 이하\n1년초과2년이하\n2년초과3년이하\n3년초과4년이하\n4년초과5년이하\n5년초과10년이하\n10년초과\n합 계\n미상환 잔액\n공모\n-\n-\n-\n-\n-\n-\n-\n-\n사모\n-\n10,000\n-\n-\n-\n40,000\n-\n50,000\n합계\n-\n10,000\n-\n-\n-\n40,000\n-\n50,000\n신종자본증권 미상환 잔액 (연결기준)\n(기준일 :\xa0\n2021년 09월 30일\n)\n(단위 : 백만원)\n잔여만기\n1년 이하\n1년초과5년이하\n5년초과10년이하\n10년초과15년이하\n15년초과20년이하\n20년초과30년이하\n30년초과\n합 계\n미상환 잔액\n공모\n-\n-\n-\n-\n-\n-\n-\n-\n사모\n-\n-\n-\n-\n-\n-\n-\n-\n합계\n-\n-\n-\n-\n-\n-\n-\n-\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0 신종자본증권 미상환 잔액 (별도기준)\n(기준일 :\xa0\n2021년 09월 30일\n)\n(단위 : 백만원)\n잔여만기\n1년 이하\n1년초과5년이하\n5년초과10년이하\n10년초과15년이하\n15년초과20년이하\n20년초과30년이하\n30년초과\n합 계\n미상환 잔액\n공모\n-\n-\n-\n-\n-\n-\n-\n-\n사모\n-\n-\n-\n-\n-\n-\n-\n-\n합계\n-\n-\n-\n-\n-\n-\n-\n-\n조건부자본증권 미상환 잔액 (연결기준)\n(기준일 :\xa0\n2021년 09월 30일\n)\n(단위 : 백만원)\n잔여만기\n1년 이하\n1년초과2년이하\n2년초과3년이하\n3년초과4년이하\n4년초과5년이하\n5년초과10년이하\n10년초과20년이하\n20년초과30년이하\n30년초과\n합 계\n미상환 잔액\n공모\n-\n-\n-\n-\n-\n-\n-\n-\n-\n-\n사모\n-\n-\n-\n-\n-\n-\n-\n-\n-\n-\n합계\n-\n-\n-\n-\n-\n-\n-\n-\n-\n-\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 조건부자본증권 미상환 잔액 (별도기준)\n(기준일 :\xa0\n2021년 09월 30일\n)\n(단위 : 백만원)\n잔여만기\n1년 이하\n1년초과2년이하\n2년초과3년이하\n3년초과4년이하\n4년초과5년이하\n5년초과10년이하\n10년초과20년이하\n20년초과30년이하\n30년초과\n합 계\n미상환 잔액\n공모\n-\n-\n-\n-\n-\n-\n-\n-\n-\n-\n사모\n-\n-\n-\n-\n-\n-\n-\n-\n-\n-\n합계\n-\n-\n-\n-\n-\n-\n-\n-\n-\n-\n7-2. 증권의 발행을 통해 조달된 자금의 사용실적\n가. 사모자금의 사용내역\n(기준일 :\xa0\n2021년 09월 30일\n)\n(단위 : 백만원)\n구 분\n회차\n납입일\n주요사항보고서의 자금사용 계획\n실제 자금사용 내역\n차이발생 사유 등\n사용용도\n조달금액\n내용\n금액\n후순위사채\n15\n2020년 03월 19일\n운영자금\n40,000\n운영자금\n40,000\n-\n']"
